These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 34062530)

  • 1. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
    Noval Rivas M; Arditi M
    Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19.
    Lee PI; Hsueh PR
    J Microbiol Immunol Infect; 2023 Apr; 56(2):236-245. PubMed ID: 36720670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.
    Keshavarz P; Yazdanpanah F; Azhdari S; Kavandi H; Nikeghbal P; Bazyar A; Rafiee F; Nejati SF; Sadabad FE; Rezaei N
    J Med Virol; 2021 Sep; 93(9):5458-5473. PubMed ID: 33969513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perineal desquamation: An early sign of the Kawasaki disease phenotype of MIS-C.
    Mazori DR; Derrick KM; Kapoor U; Haribhai M; Gist RE; Glick SA
    Pediatr Dermatol; 2021 Jan; 38(1):253-256. PubMed ID: 33222290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease 2019-associated multisystem inflammatory syndrome and Kawasaki disease.
    Uejima Y; Suganuma E; Matsunaga K; Kitajima I; Niimi H
    Pediatr Int; 2022 Jan; 64(1):e15349. PubMed ID: 36348517
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and Laboratory Characteristics of Kawasaki Disease and COVID-19-Related Multisystem Inflammatory Syndrome in Children.
    Phi DL; Dao TL; To MM; Nguyen TB; Nguyen DC; Gautret P; Hoang VT
    J Korean Med Sci; 2023 Dec; 38(49):e410. PubMed ID: 38111281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome.
    Godfred-Cato S; Abrams JY; Balachandran N; Jaggi P; Jones K; Rostad CA; Lu AT; Fan L; Jabbar A; Anderson EJ; Kao CM; Hunstad DA; Rosenberg RB; Zafferani MJ; Ede KC; Ballan W; Laham FR; Beltran Y; Bryant B; Meng L; Hammett TA; Oster ME; Bamrah Morris S; Belay ED
    Pediatr Infect Dis J; 2022 Apr; 41(4):315-323. PubMed ID: 35093995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dermatologic perspective on multisystem inflammatory syndrome in children.
    Naka F; Melnick L; Gorelik M; Morel KD
    Clin Dermatol; 2021; 39(1):163-168. PubMed ID: 33972046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease shock syndrome in the COVID-19 pandemic.
    Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
    Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): Distinct from Kawasaki disease or part of the same spectrum?
    Santaniello M; Matucci-Cerinic C; Natoli V; Trincianti C; Ridella F; Ravelli A
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):102-104. PubMed ID: 35080303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.
    Fabi M; Petrovic B; Andreozzi L; Corinaldesi E; Filice E; Biagi C; Rizzello A; Mattesini BE; Bugani S; Lanari M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.
    Fukuda S; Kaneta M; Miyake M; Ohya T; Miyakawa K; Iwamoto M; Ito S
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):442-447. PubMed ID: 33904379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucocutaneous disease and related clinical characteristics in hospitalized children and adolescents with COVID-19 and multisystem inflammatory syndrome in children.
    Rekhtman S; Tannenbaum R; Strunk A; Birabaharan M; Wright S; Garg A
    J Am Acad Dermatol; 2021 Feb; 84(2):408-414. PubMed ID: 33323343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.